804 related articles for article (PubMed ID: 22673743)
1. Endothelial dysfunction in rheumatic autoimmune diseases.
Murdaca G; Colombo BM; Cagnati P; Gulli R; Spanò F; Puppo F
Atherosclerosis; 2012 Oct; 224(2):309-17. PubMed ID: 22673743
[TBL] [Abstract][Full Text] [Related]
2. Accelerated atherosclerosis, immune response and autoimmune rheumatic diseases.
Jara LJ; Medina G; Vera-Lastra O; Amigo MC
Autoimmun Rev; 2006 Mar; 5(3):195-201. PubMed ID: 16483919
[TBL] [Abstract][Full Text] [Related]
3. Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment.
Soltész P; Kerekes G; Dér H; Szücs G; Szántó S; Kiss E; Bodolay E; Zeher M; Timár O; Szodoray P; Szegedi G; Szekanecz Z
Autoimmun Rev; 2011 May; 10(7):416-25. PubMed ID: 21281743
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of disease: atherosclerosis in autoimmune diseases.
Sherer Y; Shoenfeld Y
Nat Clin Pract Rheumatol; 2006 Feb; 2(2):99-106. PubMed ID: 16932663
[TBL] [Abstract][Full Text] [Related]
5. Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings.
Zinger H; Sherer Y; Shoenfeld Y
Clin Rev Allergy Immunol; 2009 Aug; 37(1):20-8. PubMed ID: 18991025
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic targeting of B cells for rheumatic autoimmune diseases.
Engel P; Gómez-Puerta JA; Ramos-Casals M; Lozano F; Bosch X
Pharmacol Rev; 2011 Mar; 63(1):127-56. PubMed ID: 21245206
[TBL] [Abstract][Full Text] [Related]
7. [Assessment of endothelial function in autoimmune diseases].
Benhamou Y; Bellien J; Armengol G; Gomez E; Richard V; Lévesque H; Joannidès R
Rev Med Interne; 2014 Aug; 35(8):512-23. PubMed ID: 24412013
[TBL] [Abstract][Full Text] [Related]
8. Endothelial microparticles: Pathogenic or passive players in endothelial dysfunction in autoimmune rheumatic diseases?
McCarthy EM; Wilkinson FL; Parker B; Alexander MY
Vascul Pharmacol; 2016 Nov; 86():71-76. PubMed ID: 27291140
[TBL] [Abstract][Full Text] [Related]
9. Inflammasomes and rheumatic diseases: evolving concepts.
Sidiropoulos PI; Goulielmos G; Voloudakis GK; Petraki E; Boumpas DT
Ann Rheum Dis; 2008 Oct; 67(10):1382-9. PubMed ID: 17921182
[TBL] [Abstract][Full Text] [Related]
10. Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis.
Koch AE; Distler O
Arthritis Res Ther; 2007; 9 Suppl 2(Suppl 2):S3. PubMed ID: 17767741
[TBL] [Abstract][Full Text] [Related]
11. Atherosclerosis and autoimmunity: a growing relationship.
Sanjadi M; Rezvanie Sichanie Z; Totonchi H; Karami J; Rezaei R; Aslani S
Int J Rheum Dis; 2018 May; 21(5):908-921. PubMed ID: 29671956
[TBL] [Abstract][Full Text] [Related]
12. Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment.
Murphy G; Lisnevskaia L; Isenberg D
Lancet; 2013 Aug; 382(9894):809-18. PubMed ID: 23972423
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic role of anti-endothelial cell antibodies in autoimmune rheumatic diseases.
Domiciano DS; Carvalho JF; Shoenfeld Y
Lupus; 2009 Nov; 18(13):1233-8. PubMed ID: 19880574
[TBL] [Abstract][Full Text] [Related]
14. Current perspective on rituximab in rheumatic diseases.
Schioppo T; Ingegnoli F
Drug Des Devel Ther; 2017; 11():2891-2904. PubMed ID: 29042750
[TBL] [Abstract][Full Text] [Related]
15. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
[TBL] [Abstract][Full Text] [Related]
16. Immunologic rheumatic disorders.
Joseph A; Brasington R; Kahl L; Ranganathan P; Cheng TP; Atkinson J
J Allergy Clin Immunol; 2010 Feb; 125(2 Suppl 2):S204-15. PubMed ID: 20176259
[TBL] [Abstract][Full Text] [Related]
17. At the Bench: Neutrophil extracellular traps (NETs) highlight novel aspects of innate immune system involvement in autoimmune diseases.
Grayson PC; Kaplan MJ
J Leukoc Biol; 2016 Feb; 99(2):253-64. PubMed ID: 26432901
[TBL] [Abstract][Full Text] [Related]
18. Tobacco smoking and autoimmune rheumatic diseases.
Harel-Meir M; Sherer Y; Shoenfeld Y
Nat Clin Pract Rheumatol; 2007 Dec; 3(12):707-15. PubMed ID: 18037930
[TBL] [Abstract][Full Text] [Related]
19. EC144, a synthetic inhibitor of heat shock protein 90, blocks innate and adaptive immune responses in models of inflammation and autoimmunity.
Yun TJ; Harning EK; Giza K; Rabah D; Li P; Arndt JW; Luchetti D; Biamonte MA; Shi J; Lundgren K; Manning A; Kehry MR
J Immunol; 2011 Jan; 186(1):563-75. PubMed ID: 21131419
[TBL] [Abstract][Full Text] [Related]
20. Vascular involvement in rheumatic diseases: 'vascular rheumatology'.
Szekanecz Z; Koch AE
Arthritis Res Ther; 2008; 10(5):224. PubMed ID: 18947376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
